These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 13753031)

  • 21. THE BASIS OF ITCHING.
    CORMIA FE
    J Pediatr; 1965 Jan; 66():SUPPL:207-9. PubMed ID: 14246573
    [No Abstract]   [Full Text] [Related]  

  • 22. Ferritin binds to light chain of human H-kininogen and inhibits kallikrein-mediated bradykinin release.
    Parthasarathy N; Torti SV; Torti FM
    Biochem J; 2002 Jul; 365(Pt 1):279-86. PubMed ID: 12071855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased plasma kallikrein activity and tumour growth suppression associated with intralesional bradykinin injections in hamsters.
    Koppelmann LE; Moore TC; Porter DD
    J Pathol; 1978 Sep; 126(1):1-10. PubMed ID: 722404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of kallikrein, bradykinin b2 receptor, and endothelial nitric oxide synthase in placenta in normal gestation, preeclampsia, and placenta accreta.
    Corthorn J; Germain AA; Chacón C; Rey S; Soto GX; Figueroa CD; Müller-Esterl W; Duarte I; Valdés G
    Endocrine; 2006 Jun; 29(3):491-9. PubMed ID: 16943589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and biological activity of peptides related to bradykinin.
    BOISSONNAS RA; GUTTMANN S; JAQUENOUD PA; KONZETT H; STUERMER E
    Experientia; 1960 Jul; 16():326. PubMed ID: 13802238
    [No Abstract]   [Full Text] [Related]  

  • 26. Aliskiren increases bradykinin and tissue kallikrein mRNA levels in the heart.
    Campbell DJ; Zhang Y; Kelly DJ; Gilbert RE; McCarthy DJ; Shi W; Smyth GK
    Clin Exp Pharmacol Physiol; 2011 Sep; 38(9):623-31. PubMed ID: 21736602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activity and functional significance of the renal kallikrein-kinin-system in polycystic kidney disease of the rat.
    Braun C; Kleemann T; Hilgenfeldt U; Riester U; Rohmeiss P; van der Woude FJ
    Kidney Int; 2002 Jun; 61(6):2149-56. PubMed ID: 12028455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolation and molar activity of human bradykinin.
    HAMBERG U
    Biochem Biophys Res Commun; 1962 Apr; 7():95-100. PubMed ID: 13904060
    [No Abstract]   [Full Text] [Related]  

  • 29. [Antagonism between synthetic bradykinin and phenylbutazone in the rabbit].
    LECOMTE J
    C R Seances Soc Biol Fil; 1960; 154():2389-91. PubMed ID: 13760127
    [No Abstract]   [Full Text] [Related]  

  • 30. [Antibodies to bradykinin, kallikrein and inflammation].
    Zaks AS; Bykova AA
    Patol Fiziol Eksp Ter; 1978; (3):66-7. PubMed ID: 683716
    [No Abstract]   [Full Text] [Related]  

  • 31. Characterization of the bradykinin releasing enzyme in the venom of Agkistrodon halys blomhoffii as salivary kallikrein of the snake.
    Iwanaga S; Suzuki T
    Hoppe Seylers Z Physiol Chem; 1968 Jul; 349(7):928-9. PubMed ID: 5303673
    [No Abstract]   [Full Text] [Related]  

  • 32. Identification of porcine follipsin as plasma kallikrein, and its possible involvement in the production of bradykinin within the follicles of porcine ovaries.
    Kimura A; Kihara T; Okimura H; Hamabata T; Ohnishi J; Moriyama A; Takahashi K; Takahashi T
    Mol Reprod Dev; 2000 Sep; 57(1):79-87. PubMed ID: 10954859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The radioimmunoassay of bradykinin in the measurement of kallikrein in urine.
    Macfarlane NA; Adetuyibi A; Mills IH
    J Endocrinol; 1973 Jul; 58(1):xxv. PubMed ID: 4722552
    [No Abstract]   [Full Text] [Related]  

  • 34. The hyaluronan-binding serine protease from human plasma cleaves HMW and LMW kininogen and releases bradykinin.
    Etscheid M; Beer N; Fink E; Seitz R; Johannes D
    Biol Chem; 2002 Oct; 383(10):1633-43. PubMed ID: 12452440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hageman factor-dependent pathways: mechanism of initiation and bradykinin formation.
    Kaplan AP
    Fed Proc; 1983 Nov; 42(14):3123-7. PubMed ID: 6556144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Activation of the kallikrein-bradykinin system in acute renal failure].
    Criscuolo ME; Finkielman S; Nahmod VE
    Medicina (B Aires); 1977; 37 Suppl 2():33-29. PubMed ID: 909391
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of vibration on the activity of the plasma kallikrein-kinin system in the rat.
    Gáti T; Budavári I; Szombath D; Losonczy G
    Acta Physiol Acad Sci Hung; 1982; 60(4):213-8. PubMed ID: 6926659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regression of glomerular injury by kallikrein infusion in Dahl salt-sensitive rats is a bradykinin B2-receptor-mediated event.
    Hirawa N; Uehara Y; Suzuki T; Kawabata Y; Numabe A; Gomi T; lkeda T; Kizuki K; Omata M
    Nephron; 1999 Feb; 81(2):183-93. PubMed ID: 9933754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary kallikrein excretion during bradykinin and eledoisin infusions and its relationship to urinary osmolality [proceedings].
    Mills IH; Obika LF
    J Physiol; 1977 Jul; 269(1):72P-73P. PubMed ID: 894582
    [No Abstract]   [Full Text] [Related]  

  • 40. Potent antihypertrophic effect of the bradykinin B2 receptor system on the renal vasculature.
    Tsuchida S; Miyazaki Y; Matsusaka T; Hunley TE; Inagami T; Fogo A; Ichikawa I
    Kidney Int; 1999 Aug; 56(2):509-16. PubMed ID: 10432390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.